Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.34, demonstrating a +1.21% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.38%.

Bitcoin (BTC-USD) opened at $63,745.37 on Monday, July 13, 2026, 0.2% lower than Sunday's opening price. As of 9:30 a.m. ET this morning, the price of bitcoin moved down to $62,555.13. Ethereum ...

Start-ups are paying white-collar professionals to teach their jobs to artificial intelligence models. It’s a bonanza. It’s bleak. Where will it end? Marta CerdàCredit... Supported by By Lora Kelley ...

A language takes work off your hands, gives it to a compiler, runtime, or toolchain, and charges you somewhere else.

Before the US government took it offline, Fable 5 was an impressive AI model, with top-notch intelligence outweighing quirks around pricing and more. However, I'm far less enthusiastic about the ...